Equivalence in Periodontal Trials: A Description for the Clinician

Journal of Periodontology

Volumn 69, Issue 6, 1998, Pages 650-654

  Duke, Susan P ^a,b   Garrett, Steven ^a  

^a QLT Inc   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Clinical trials; Statistics; Therapeutic equivalency; Therapeutic lack of significance

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; FOLLOW UP; HUMAN; METHODOLOGY; MOUTH HYGIENE; PERIODONTAL DISEASE; PERIODONTITIS; PREVENTIVE DENTISTRY; PROBABILITY; SAMPLE SIZE; STATISTICS;

CLINICAL TRIALS; CONFIDENCE INTERVALS; DENTAL SCALING; FOLLOW-UP STUDIES; HUMANS; ORAL HYGIENE; PERIODONTAL DISEASES; PERIODONTITIS; PROBABILITY; RESEARCH DESIGN; ROOT PLANING; SAMPLE SIZE;

EID: 0032084764     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1998.69.6.650     Document Type: Article

References (8)

1. Larson HJ. Introduction to Probability Theory and Statistical Inference, 3rd ed. New York: John Wiley & Sons; 1982:413.
2. Westlake WJ. Use of confidence intervals in analysis of comparative bioavailability trials. J Pharmac Sci 1972;61:1340-1341.
3. Westlake WJ. Symmetrical confidence intervals for bioequivalence trials. Biometrics 1976;32:741-744.
4. Westlake WJ. Statistical aspects of comparative bioavailability trials. Biometrics 1976;35:273-280.
5. Metzler CM. Bioavailability - a problem in equivalence. Biometrics 1974;30:309-317.
6. Blackwelder WC. "Proving the null hypothesis" in clinical trials. Controlled Clinical Trials 1982;3:345-353.
7. Westlake WJ. In: Peace KE, ed. Biopharmaceutical Statistics for Drug Development. New York: Marcel Dekker; 1988;342.
8. Gunsolley JC, Elswick RK. Equivalence and superiority testing in regeneration clinical trials. J Periodontol 1998;69:523-529.